Concepedia

Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold

Mingze Qin, Qi Cao, Xia Wu, Chunyang Liu, Shuaishuai Zheng, Hongbo Xie, Ye Tian, Jun Xie, Yanfang Zhao, Yunlei Hou,

European Journal of Medicinal Chemistry · 2019 · 51 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

, , +17

Cancer Immunotherapy

Jennifer Couzin-Frankel · Science · 2013 · 2K citations

, , +13

Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses

Manish J. Butte, Mary Keir, Theresa B. Phamduy et al. · Immunity · 2007 · 1.7K citations · Full text

, , +16

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

Corey J. Langer, Shirish M. Gadgeel, Hossein Borghaei et al. · The Lancet Oncology · 2016 · 1.4K citations

, , +13

Tissue expression of PD-L1 mediates peripheral T cell tolerance

Mary Keir, Spencer C. Liang, Indira Guleria et al. · The Journal of Experimental Medicine · 2006 · 1.2K citations · Full text

, , +17